Skip to content

Comparison of Single and Continuous Adductor Canal Block for Analgesic Efficacy After Unicompartmental Knee Arthroplasty: A Randomized, Unblinded, Controlled Study

Comparison of Single and Continuous Adductor Canal Block for Analgesic Efficacy After Unicompartmental Knee Arthroplasty: A Randomized, Unblinded, Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081956
Enrollment
Unknown
Registered
2024-03-18
Start date
2023-08-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

single adductor canal block group:Patients undergoing unicompartmental knee arthroplasty received a single adductor canal block
continuous adductor canal block group:Patients undergoing unicompartmental knee arthroplasty received a continuous adductor canal block

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (i) Patients undergoing unicompartmental knee arthroplasty for knee Osteoarthritis with a single medial compartment; (ii) Age 18-90 years, ASA classification I-III, BMI 18-35 kg/m2; (iii) Signed consent for analgesia, agreeing to the use of adductor canal blcok as one of the analgesic regimens in the postoperative period.

Exclusion criteria

Exclusion criteria: (i) total knee arthroplasty, knee unicondylar replacement for osteoarthritis of the knee in the lateral compartment, simultaneous bilateral knee arthroplasty, revision surgery; (ii) contraindications to adductor canal block (localized infections, sepsis, pre-existing neuropathy of the lower extremities); (iii) history of chronic pain unrelated to the knee joint that requires long-term use of opioid medications, alcohol, or other drug abuse; (iv) allergy to local anesthesia; (v) difficulty in comprehending scales such as visual analog scoring pain scores.

Design outcomes

Primary

MeasureTime frame
Visual analog scoring;Opioid consumption;

Secondary

MeasureTime frame
First straight leg raise time;Breakthrough Pain Time;Days of stay in hospital;complications;muscle power of the affected limb;Walking test;Knee flexion angle;Knee function score;

Countries

China

Contacts

Public ContactWeijie Lu

The First Affiliated Hospital of Guangzhou Medical University

13902280296@139.com+86 139 0228 0296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026